Sarcoidosis, Pulmonary Clinical Trial
Official title:
PHENOtype Based Therapy With Antibiotics in SARcoidosis Patients With and Without Presence of Cutibacterium Acnes in Granulomatous Tissue
In this study it is investigated whether treatment with azithromycin in combination with doxycycline reduces the bacterial load of C. acnes in granulomatous tissue of patients with sarcoidosis and subsequently decreases the inflammatory activation measured by FDG uptake and serum biomarkers.
Status | Not yet recruiting |
Enrollment | 40 |
Est. completion date | June 30, 2023 |
Est. primary completion date | April 30, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Biopsy proven sarcoidosis. - No treatment indication for the sarcoidosis - Inflammatory activity according to FDG-PET scan at baseline - SUVmax above 3 in the lung and/or above 5 in mediastinum/hili Exclusion Criteria: - Increased duration of QT interval (>440ms for men and >450ms for women) on ECG - Hearing deficits, as this is a possible side effect of azithromycin - Being pregnant or breastfeeding at time of inclusion |
Country | Name | City | State |
---|---|---|---|
Netherlands | St. Antonius Hospital | Nieuwegein | Utrecht |
Lead Sponsor | Collaborator |
---|---|
St. Antonius Hospital | ZonMw: The Netherlands Organisation for Health Research and Development |
Netherlands,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | serum biomarker: ACE | Determine whether treatment with azithromycin and doxycycline changes levels of serum biomarker Angiotensin Converting Enzyme (ACE) in U/I in sarcoidosis patients | 2 weeks | |
Other | serum biomarker: IL-2R | Determine whether treatment with azithromycin and doxycycline changes levels of serum biomarker interleukin-2receptro (IL-2R) in pg/mL in sarcoidosis patients | 2 weeks | |
Primary | SUVmax | Difference of standarized uptake value (SUVmax) uptake after treatment with antibiotics between patients with and without C. acnes in their granuloma | 2 weeks | |
Secondary | lung function | Difference in FVC after treatment with antibiotics between patients with and without C. acnes in their granulomatous tissue | 2 weeks | |
Secondary | quality of life according to questionnaire | Monitor quality of life for patients treated with antibiotics compared to patients receiving placebo, measured by King's Sarcoidosis Questionnaire that is taken at baseline and end of study. QOL is measured with the King's Sarcoidosis Questionnaire (KSQ), which is a validated questionnare on sarcoidosis with 5 scales and 29 items. | 2 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04020380 -
Azithromycin a Treatment for Pulmonary Sarcoidosis
|
Phase 2 | |
Recruiting |
NCT03260556 -
Pirfenidone for Progressive Fibrotic Sarcoidosis
|
Phase 4 | |
Completed |
NCT05759221 -
Peripheral Airway Biopsy in Sarcoidosis
|
N/A | |
Completed |
NCT03336736 -
The Role of Physical Activity and Diet Within Pulmonary Sarcoidosis
|
||
Completed |
NCT03140644 -
SARCOLOWDOSE : Ultra-low Dose CT Scan and MRI in Thoracic Sarcoidosis
|
N/A | |
Completed |
NCT03793439 -
Tofacitinib Hypothesis-generating, Pilot Study for Corticosteroid-Dependent Sarcoidosis
|
Phase 1 | |
Recruiting |
NCT04895111 -
Endobronchial Ultrasound Strain Elastography in Sarcoidosis
|
||
Not yet recruiting |
NCT05910554 -
Investigation of the Efficacy of Metformin Therapy on Pulmonary Sarcoidosis
|
Phase 2 | |
Recruiting |
NCT05374447 -
Diagnostic Yield of Intranodal Forceps Biopsies in Mediastinal Adenopathy
|
N/A | |
Active, not recruiting |
NCT04314193 -
Effectiveness of Methotrexate Versus Prednisolone as First-line Therapy for Pulmonary Sarcoidosis
|
Phase 4 | |
Completed |
NCT03727451 -
A Dose Escalation Study to Assess the Safety and Efficacy of Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Fibrosis or Sarcoidosis
|
Phase 2 | |
Recruiting |
NCT05746039 -
Feasibility of Semaglutide in Advanced Lung Disease
|
Phase 1/Phase 2 | |
Completed |
NCT04803617 -
Investigation of Pectoralis Muscle Strength in Elderly With Interstitial Lung Disease
|
||
Recruiting |
NCT03145922 -
Epigenetic Regulation of Altered T-cell Immunity in Sarcoidosis
|
||
Completed |
NCT00279708 -
Atorvastatin to Treat Pulmonary Sarcoidosis
|
Phase 2 | |
Recruiting |
NCT05567133 -
Risk Indicators of Sarcoidosis Evolution-Unified Protocol
|
||
Completed |
NCT05311150 -
An RCT of NBI vs. White Light Guided Endobronchial Biopsy in Suspected Sarcoidosis
|
N/A | |
Completed |
NCT05811962 -
The Diagnostic and Prognostic Role of SAA in Intrathoracic Sarcoidosis
|
||
Completed |
NCT03320070 -
Acthar Gel in Participants With Pulmonary Sarcoidosis
|
Phase 4 | |
Completed |
NCT03324503 -
A Study to Estimate the Effect Sizes of HRCT Endpoints in Response to Glucocorticoid Induction Therapy in Subjects With Pulmonary Sarcoidosis
|
N/A |